Okayama University Pioneers Innovative ETA Treatment for Overactive Bladder Symptoms Okayama University has developed an innovative treatment for refractory overactive bladder symptoms called ETA therapy, marking a significant advancement in clinical methods.

Okayama University Pioneers Innovative ETA Treatment for Overactive Bladder Symptoms #Japan #Overactive_Bladder #Okayama #Okayama_University #ETA_therapy

Study Reveals Higher Adherence to Pelvic Floor Therapy in Overactive Bladder Patients Without Medications A recent study found that overactive bladder patients show better adherence to pelvic floor physical therapy when not combined with medications, enhancing treatment efficacy.

Study Reveals Higher Adherence to Pelvic Floor Therapy in Overactive Bladder Patients Without Medications #USA #Pittsburgh #Overactive_Bladder #AHN #Pelvic_Floor_Therapy

Rodney Peete and Sumitomo Pharma America Urge Open Discussion for Overactive Bladder Awareness Sumitomo Pharma America's Time To Go™ campaign features Rodney Peete to encourage discussions about overactive bladder symptoms and treatment options, promoting GEMTESA as a solution.

Rodney Peete and Sumitomo Pharma America Urge Open Discussion for Overactive Bladder Awareness #USA #Marlborough #GEMTESA #Overactive_Bladder #Rodney_Peete

Sumitomo Pharma America Gains FDA Approval for GEMTESA® to Treat OAB Symptoms in Men with BPH Sumitomo Pharma America announces FDA approval of GEMTESA® (vibegron) for men with overactive bladder symptoms linked to benign prostatic hyperplasia, enhancing treatment options.

Sumitomo Pharma America Gains FDA Approval for GEMTESA® to Treat OAB Symptoms in Men with BPH #USA #Marlborough #GEMTESA #Sumitomo_Pharma #Overactive_Bladder